We NEED to Talk About Statins
In a Nutshell
Statins are overprescribed for primary prevention based on LDL thresholds, yielding minimal absolute risk reduction (e.g., NNT in hundreds) while ignoring root causes like insulin resistance and metabolic disease, driven by pharma profits and simplistic doctor practices. For secondary prevention with plaque, low-dose rosuvastatin (e.g., 5mg 2-3x/week) offers anti-inflammatory and plaque-stabilizing benefits with fewer side effects like diabetes risk compared to high doses. Prioritize a 4-step framework: detect issues via advanced tests (CIMT, calcium score, fractionation), reset metabolism through lifestyle, use supplements, and add low-dose meds only for high-risk cases—never chase LDL numbers alone.
These notes were generated by AI and may contain inaccuracies.
Over 200 million people take statins daily, making them one of the most prescribed drugs in history, yet people still have heart attacks. Doctors overprescribe statins, especially high-dose ones. Not the patients win from this. Discussion on whether statins are necessary to avoid heart attacks and Dr. Ford Brewer's approach after 40 years in prevention. Dr. Brewer with Dr. Jesus Vega.
In the US, current guidelines mean 40% or more of older adults qualify for statins for primary prevention (patients appear healthy, no prior cardiac event or cardiovascular diagnosis). Doctors prescribe based on LDL levels: used to be over 120, then 100, then 70, now some guidelines say 55. Standards committees say it's more than just LDL, but doctors treat it as such.
Primary prevention benefit-harm math does not hold: NNT (number needed to treat) is very large; risk reduction over 5 years often single digits. Relative risk vs absolute risk key issue.
Example: One major trial reported 46% relative reduction in strokes, but absolute risk was 1.3% (13 fewer strokes per 1000 people over 4 years). Patients shown 46%, not 1.3%. David Diamond discussed this. Guidelines expanded qualifiers, increasing NNT and dropping absolute benefit further with lower LDL threshold to 55, without updating benefit communication.
Doctors use LDL as threshold because it's simple: check blood test, prescribe if over threshold. LDL called "bad cholesterol," but not really. Evidence for LDL role in heart disease is real and substantial, but prevention shouldn't begin and end with LDL. Cardiovascular risk is multifactorial.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.